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The importance of the epicardium for myocardial and valvuloseptal development has been well
established; perturbation of epicardial development results in cardiac abnormalities, including thinning
of the ventricular myocardial wall and malformations of the atrioventricular valvuloseptal complex. To
determine the spatiotemporal contribution of epicardially derived cells to the developing ﬁbroblast
population in the heart, we have used a mWt1/IRES/GFP-Cre mouse to trace the fate of EPDCs from
embryonic day (ED)10 until birth. EPDCs begin to populate the compact ventricular myocardium
around ED12. The migration of epicardially derived ﬁbroblasts toward the interface between compact
and trabecular myocardium is completed around ED14. Remarkably, epicardially derived ﬁbroblasts do
not migrate into the trabecular myocardium until after ED17. Migration of EPDCs into the atrioven-
tricular cushion mesenchyme commences around ED12. As development progresses, the number of
EPDCs increases signiﬁcantly, speciﬁcally in the leaﬂets which derive from the lateral atrioventricular
cushions. In these developing leaﬂets the epicardially derived ﬁbroblasts eventually largely replace the
endocardially derived cells. Importantly, the contribution of EPDCs to the leaﬂets derived from the
major AV cushions is very limited. The differential contribution of EPDCs to the various leaﬂets of the
atrioventricular valves provides a new paradigm in valve development and could lead to new insights
into the pathogenesis of abnormalities that preferentially affect individual components of this region of
the heart. The notion that there is a signiﬁcant difference in the contribution of epicardially and
endocardially derived cells to the individual leaﬂets of the atrioventricular valves has also important
pragmatic consequences for the use of endocardial and epicardial cre-mouse models in studies of heart
development.
& 2012 Elsevier Inc. All rights reserved.Introduction
Fibroblasts and ﬁbroblast-like cells form the largest non-
cardiomyocyte cell population in the developed heart (Banerjee
et al., 2007) and play an important role in cardiac function,
remodeling, and disease (Prunotto et al.; Vasquez et al.). Not all
ﬁbroblast/ﬁbroblast-like cells in the heart are the same (Krenning
et al., 2010; Snider et al., 2009; Zeisberg and Kalluri, 2010). Thell rights reserved.
uscriptﬁbroblasts found embedded in the interstitial space of the
myocardium are generally referred to as cardiac ﬁbroblasts
(CFs) while the ﬁbroblast-like cells in the interstitium of the
respective cardiac valves are commonly known as valve inter-
stitial cells (VICs) or valvular ﬁbroblasts (VFs),
In the initial papers that reported on the contribution of the
epicardium to the developing heart using a variety of cell fate
tracing techniques, results were presented that convincingly
showed that after an epicardial-to-mesenchymal transformation
a subset of epicardially derived cells (EPDCs) migrate into the
ventricular walls (Dettman et al., 1998; Gittenberger-de Groot
et al., 1998; Manner, 1999). Here they give rise to a number of
more differentiated cell types including the CFs and the coronary
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Pomares, 2004). During this process, differentiating EPDCs
gradually lose expression of genes typically expressed in the
epicardium, including cytokeratin, Tbx18, Wt1 and RALDH2
(Perez-Pomares et al., 2002) while at the same time upregulating
genes associated with the more differentiated cell types. A
comprehensive spatiotemporal analysis of the contribution of
the EPDCs to the CF population has not, however, been published.
Similarly, although several studies have demonstrated that EPDCs
also populate the mesenchyme of the developing atrioventricular
(AV) cushions (Gittenberger-de Groot et al., 1998; Manner, 1999;
Perez-Pomares et al., 2002), the question of whether EPDCs also
materially contribute to the VICs in the developed AV valve
leaﬂets has not been resolved.
Most of our current understanding on the importance of the
epicardium in the formation of the different ﬁbroblast subpopu-
lations is based on experimental studies using avian model
systems (Manner, 1999; Gittenberger-de Groot et al., 2000; Lie-
Venema et al., 2007; Perez-Pomares et al., 2002). More recently,
however, our ability to study the speciﬁc contribution of EPDCs to
the developing heart has been furthered by transgenic mouse
technology, including the cGATA5-cre (Merki et al., 2005), the
Tbx18-cre (Cai et al., 2008), the inducible Wt1-cre (Zhou et al.,
2008), the inducible Tcf21-cre mouse (Acharya et al., 2011), and
the Sema3DeGFPcre knock-in and ScxGFPCre BAC transgenic mice
(Katz et al., 2012). Studies utilizing these mouse models have,
however, primarily focused on the possible contribution of EPDCs
to the cardiac muscle, the role of epicardial EMT in the develop-
ment of the AV sulcus, and/or the role of the epicardium in
coronary development (Cai et al., 2008; Smart et al., 2011; Zhou
et al., 2008, 2010; Merki et al., 2005; Katz et al., 2012; Mellgren
et al., 2008). As a result, still little is known regarding the
contribution of EPDCs to the respective ﬁbroblast populations in
the developing and mature mammalian heart.
In this study, we focused on the contribution of EPDCs to
emerging populations of ﬁbroblasts and ﬁbroblast-like cells with
a speciﬁc emphasis on the developing AV valves. The AV valves
ensure unidirectional ﬂow of blood from atria to ventricles and
are largely derived from two sets of mesenchymal AV cushions.
The two major AV cushions are the ﬁrst to develop while the two
lateral AV cushions appear later (de Lange et al., 2004; Wessels
et al., 1996; Wessels and Sedmera, 2003). The mesenchyme found
in the early AV cushions derives from an endocardial epithelial-
to-mesenchymal transition (EMT) (de Lange et al., 2004;
Markwald et al., 1977; Runyan and Markwald, 1983; Snarr
et al., 2008). During valvuloseptal morphogenesis, the major AV
cushions fuse, take part in the formation of the AV mesenchymal
complex and contribute to the formation of the aortic leaﬂet of
the left AV valve and the septal leaﬂet of the right AV valve (Snarr
et al., 2007a, 2007b). The lateral AV cushions do not fuse with
each other or other mesenchymal tissues, but contribute to the
parietal leaﬂet of the right AV valve and the mural leaﬂet of the
left AV valve (de Lange et al., 2004; Wessels and Sedmera, 2003).
Eventually, the cushion mesenchyme differentiates and gives rise
to the valve interstitial cells (VICs). For many years, it was
generally accepted that all VICs were endocardially derived. More
recent studies, however, have demonstrated that circulating bone
marrow-derived cells can engraft into the valves and also con-
tribute to the VIC population (Hajdu et al., 2011). Although
several studies in avian model systems have demonstrated that
EPDCs contribute to the mesenchyme of the developing AV
cushions (Gittenberger-de Groot et al., 1998; Manner, 1999;
Perez-Pomares et al., 2002), a contribution of the EPDCs to the
VIC population in the formed AV valves has never been reported.
In fact, based on immunohistochemical studies on quail-to-chick
epicardial chimeras it has been suggested that the epicardialcontribution to the developing valves is only temporary and that
the formed leaﬂets of the AV valves do not contain cells with an
epicardial origin (de Lange et al., 2004). The development of the
AV valves is intrinsically related to the formation of the annulus
ﬁbrosus, a sheet of ﬁbrous tissue physically separating the atrial
and ventricular working myocardium at the AV junction. This
ﬁbrous tissue is important to the prevention of ventricular pre-
excitation, allowing sequential contraction of atrial and ventricu-
lar chambers and aiding in the unidirectional ﬂow of blood
through the heart (Wessels et al., 1991, 1996). While recent
publications have provided new insights into the role of the
epicardium in the formation of the annulus ﬁbrosus (Kolditz
et al., 2008; Zhou et al., 2010) it is surprising how little informa-
tion exists regarding the role of the epicardium in the formation
of the AV valve leaﬂets which are in ﬁbrous continuity with the
annulus ﬁbrosus. In this paper we focus on this important aspect
of valvuloseptal development.
The mouse model used in this study, the mWt1/IRES/GFP-Cre
(Wt1Cre) mouse, was designed based on the preferential expres-
sion of the transcription factor Wilm’s Tumor 1 (Wt1) in the
epicardium (Moore et al., 1999; Perez-Pomares et al., 2002). To
trace the fate of epicardially derived cells we crossed this mouse
with the R26-mT/mG reporter mouse(Muzumdar et al., 2007) and
used immunoﬂuorescence to follow the fate of epicardially
derived cells in detail.Methods
Generation and characterization of the mWt1/IRES/GFP-cre mouse
To determine the fate of EPDCs in the valvuloseptal complex of
the developing murine heart, bacterial artiﬁcial chromosome
(BAC) transgenesis was used to generate a mWt1/IRES/GFP-Cre
(Wt1Cre) mouse (see also (del Monte et al., 2011)). To achieve this,
an IRES/EGFP-Cre cassette was inserted 17 bp downstream of the
translation stop site of the Wt1 gene in the BAC clone RP23-
266M16 of the mouse RPCI-23 (C57BL/6 J) BAC library (http://
bacpac.chori.org). This BAC clone ranged from 127 kbp to
þ11.5 kbp relative to the transcription start site of Wt1.
Epicardial and endocardial cell-fate tracing
To trace the fate of epicardially and endocardially derived cells the
mWt1/IRES/GFP-Cre mouse and the Tie2-cre mouse (Kisanuki et al.,
2001) were used in combination with the B6.129(Cg)-Gt(ROSA)26-
Sortm4(ACTB-tdTomato,–EGFP)Luo/J reporter mouse, or R26-mT/mG mouse.
Expression of EGFP after cre-recombination in the Wt1cre::R26-mT/
mG mouse (Wt1cre-mG) and Tie2::R26-mT/mG mouse (Tie2cre-mG)
specimens was detected by immunoﬂuorescence.
Immunoﬂuorescent detection of EGFP and other antigens on
Wt1cre-mG and Tie2cre-mG specimens.
After sacriﬁcing time-pregnant dams, embryos were isolated in
phosphate-buffered saline (PBS), ﬁxed overnight in freshly dissolved
paraformaldehyde (4% w/v in PBS), processed through a graded series
of ethanol, cleared in toluene, embedded in Paraplast Plus (Fisher
Brand, catnr: 23-021-400), serially sectioned, mounted on Superfrost/
Plus microscope slides (Fisherbrand catnr: 12-550-15) and stored at
room temperature. In addition we collected Wt1cre-mG hearts of
neonates right after birth (ND0). Staging and hematoxylin/eosin
staining were performed as previously described (Waller and
Wessels, 2000; Snarr et al., 2007a, 2007b). To determine the devel-
opmental fate of the EPDCs, as well as to establish their relationship
to other cell populations in the developing and postnatal heart, a
Fig. 1. Wilm’s Tumor 1 (Wt1) mRNA and protein expression in the developing mouse
heart. Non-radioactive in situ hybridization on serial sections of mouse embryos at
11.5ED (A), (B) and 13.5ED (C), (D) for cardiac Troponin I (cTnI; (A), (C) andWt1 (B), (D)
shows expression of Wt1 mRNA in the epicardium covering the surface of the heart
(white arrow heads in (B) and (D), in isolated cells in the interventricular septum (black
arrows in D), and cells in the ventricular free wall (white arrows in (D). Immunolabel-
ing for Wt1 at 13.5ED (green nuclei in (E), (F) shows the expression of Wt1 protein in
the epicardial epithelium (white arrowheads in (F) as well as cells in the ventricular
wall (white arrows in (E) and (F) mimicking the expression proﬁle observed for Wt1
mRNA in the in situ hybridization. Double immunoﬂuorescent labeling for Wt1 (green
nuclei in (G) and Wt1cre-mG cells (red in (G) at 10ED shows the Wt1 driven expression
of EGFP in the epicardium covering the myocardium of the early embryonic heart.
A. Wessels et al. / Developmental Biology 366 (2012) 111–124 113panel of antibodies against a series of antigens was applied, including
EGFP (Abcam ab 13970), Wt1 (Santa Cruz; catnr sc-192), Myosin
Heavy Chain (MF20; DSHB), Troponin I (TnI; MilliPore; catnr
MB1691), Sox9 (Santa Cruz, catnr sc-20095), FilaminA (Epitomics,
catnr 2242-1), Vimentin (Epitomics; catnr 27071), Collagen I (MD
Bioscience; catnr 203002), Collagen I a1 Telopeptide (PhospoSolu-
tions; catnr 322-COLT), and pSMAD1,5,8 (rabbit polyclonal, Millipore;
catnr AB3848). Prior to incubation with primary antibodies, slides
were typically pretreated with 15ml of Vector Biolabs antigen
unmasking solution (cat H-3300) in 1600ml of distilled water for
ﬁve minutes in a pressure cooker (Fagor Splendid, item 918060616),
followed by preincubation with 1% bovine serum albumin (BSA) in
PBS. Secondary antibodies (Jackson Immunoresearch) used included
donkey anti-rabbit TRITC (711-025-152), donkey anti-chicken 649
(703-495-155), and donkey anti-mouse FITC (715-095-151). Nuclei
were visualized using either Topro3 (Molecular Probes; 1:500) or
DAPI (Invitrogen; Slowfade Gold Antifade Reagent with DAPI).
Fluorescence was visualized using either a Leica SPE confocal laser
scanning microscope or a Zeiss AxioImager II microscope.
In situ hybridization
After sacriﬁce of time-pregnant dams, embryos were isolated in
ice-cold phosphate-buffered saline (PBS) and dissected, ﬁxed over-
night in freshly dissolved 4%(w/v) paraformaldehyde (PFA) in PBS,
and embedded in paraplast. In situ hybrization was performed
essentially as previously described (Kruithof et al., 2006). The
embryos were sectioned at 10 mm, deparafﬁnized, rehydrated in a
graded series of alcohol and incubated with 10mg/ml proteinase K
dissolved in PBS for 15min at 37 1C. The proteinase K activity was
blocked by rinsing the sections in 0.2% glycine in PBST
(PBSþ0.05%Tween-20) for 5 min. After rinsing in PBS, the sections
were post-ﬁxed for 10 min in 4% PFA and 0.2% glutaraldehyde in PBS,
followed by rinsing in PBS. After pre-hybridization for at least 1 h at
70 1C in hybridization mix (50%formamide, 5 SSC (20 SSC; 3 M
NaCl, 0.3 M tri-sodium citrate, pH 4.5), 1% blocking solution (Roche),
5 mM EDTA, 0.1% 3-[(3-cholamidopropyl) dimethylammonio]-1-pro-
panesulfonate (Sigma; Steinheim, Germany), 0.5 mg/ml heparin (BD
Biosciences; Erembodegem, Belgium), and 1mg/ml yeast totalRNA
(Roche), a digoxigenin (DIG)-labeled probe was added to the hybri-
dization mix in a ﬁnal concentration of 1 ng/ml. For the detection of
Wt1, a 3.1 kb full length cDNA probe (Genebank, NM_144783) was
used recognizing all Wt1 isoforms. Additionally, probes were used
speciﬁc to cardiac Troponin I (cTnI), and SOX9. After overnight
hybridization, the sections were rinsed with 2xSSC, followed by two
washes with 50% formamide, 2 SSC, pH 4.5, at 65 1C, and rinsing in
TNT (0.1 M Tris–HCl, pH¼7.5, 0.15M NaCl, 0.05% Tween-20) at room
temperature. Subsequently, the sections were incubated for 1 h in
MABT-block (100mM Maleic Acid, 150mM NaCl, pH7.4, 0.05%
Tween-20, 2% blocking solution), followed by 2 h incubation in
MABT-block containing 100mU/ml alkaline phosphatase-conjugated
anti-DIG Fab fragments (Roche catnr: 1093274). After rinsing in TNT
and subsequently in NTM (100mM Tris pH9.0 100mM NaCl, 50 mM
MgCl2), probe binding was visualized using nitro blue tetrazolium
chloride and 5-bromo-4-chloro-3-indolyl-phosphate (Roche catnr:
1681451). Color development was stopped by rinsing in double-
distilled water. The sections were dehydrated in a graded ethanol
series, rinsed in xylene, and embedded in Entellan. Images were
recorded using a Leica DFC320 camera mounted on an AxioPhot
microscope (Zeiss).IVS¼ interventricular septum, LA¼ left atrium, LV¼ left ventricle, RA¼right atrium;
RV¼right ventricle.Nomenclature
The anatomy of the AV valves in the mouse resembles, to a
certain extent, that of the AV valves in the human heart. However,while the right AV valve in the human has a pronounced three
leaﬂet conﬁguration, and hence is referred to as the tricuspid
valve, in the mouse the anatomy of the right AV valve is better
A. Wessels et al. / Developmental Biology 366 (2012) 111–124114described as a two-leaﬂet valve comprised of a septal leaﬂet,
deriving from the fused major cushions and a parietal leaﬂet,
deriving from the right lateral AV cushion, respectively (Icardo
et al., 1993). The left AV valve, is, like in humans, also a two-
leaﬂet valve and consists of the aortic leaﬂet, which, like the
septal leaﬂet of the right AV valve, derives from the major AV
cushions, and the mural leaﬂet, deriving from the left lateral AV
cushion. In this paper we will, to facilitate description and
discussion, on occasion refer to the parietal and mural leaﬂets
as the lateral AV leaﬂets, while the septal leaﬂet of the right AV
valve and the aortic leaﬂet of the left AV valve may be referred to
as the septal AV leaﬂets.Fig. 2. Epicardial cell fate tracing with the Wt1cre mouse demonstrates timeline of how
ventricular myocardium. Tissue sections of 10.5ED (A)–(A00), 12.5ED (B)–(B00), 14ED (C)–
HE (A)–(D), and immunoﬂuorescently for EGFP (red) and MF20 (green) demonstrate
between 12.5ED (B0), (B00) and 14ED (C0), (C00). Panels E and F show the distribution of EG
Comparison between the distribution of EGFP labeled cells at 14ED (C0), (C00) and 17ED
developmental window. The sections of the neonatal heart show that by this time th
Arrows in panels (A)–(D00) demonstrate the thickness of compact myocardium at t
TM¼trabecular myocardium.Results
Wilm’s tumor 1 (Wt1) transcription factor is expressed in epicardial
and epicardially derived cells
One of the genes critically important for epicardial development
is the transcription factor Wilm’s Tumor 1 (Wt1) (Moore et al.,
1999). Wt1 expression has been demonstrated in the epicardium
and a subset of epicardially derived cells in the avian and mouse
heart (Moore et al., 1999; Perez-Pomares et al., 2002; Zeng et al.,
2011; Zhou et al., 2008). Based on the ‘‘epicardial-speciﬁc’’
expression of Wt1 mRNA and protein, an mWt1/IRES/GFP-Creepicardially derived interstitial ﬁbroblasts populate the compact and trabecular
(C00) and neonatal (D)–(D00) hearts of Wt1cre-mG specimens histologically stained for
how EGFP-labeled EPDCs start to populate the compact ventricular myocardium
FP expressing cells (white) at 17ED and in the neonatal heart at low magniﬁcation.
(E) show that the EPDCs remain conﬁned to the compact myocardium within that
e migration of EPDCs into the trabecular myocardium is complete (D0)–(D00), (F).
he respective stages. CM¼compact myocardium, IVS¼ interventricular septum,
Fig. 3. Wt1cre-mG expressing EPDCs within the ventricular myocardium of the late
fetal heart are restricted to the compact myocardium and form the population of
interstitial cardiac ﬁbroblasts. Panels A-D show immunoﬂuorescent labeling of
Wt1cre-mG hearts at 17ED for EGFP expression (red, (A)–(C), MF20 (green, (B)–(D),
and nuclear DAPI staining (blue, (A)–(B), and demonstrates that at this late fetal
stage, EPDCs have not yet populated the trabecular myocardium (A), (B). The
Wt1cre-mG cells have a characteristic mesenchymal/ﬁbroblastic phenotype, and do
not express myocardial speciﬁc genes (arrows in (B)–(D). Co-labeling of sections of
17ED Wt1cre-mG hearts for EGFP expression (red in (E), (H), (K), (N), for FilaminA
(green in (F), (G), (I), (J) and Vimentin (green in (L), (M), (O), (P) antibodies as well
as the staining for Collagen I a1 Telopeptide Z (green in (Q), (R) in combination
with the staining for EGFP expression (red in (Q) and (R) conﬁrms the ﬁbroblastic
nature of the majority of EGFP labeled cells, (H)–(J) are enlargements of boxed
areas in (E)–(G); (N)–(P) are enlargements of boxed areas in (K)–(M); (R) is an
enlargement of boxed area in (Q). CM¼compact myocardium, TM¼trabecular
myocardium.
A. Wessels et al. / Developmental Biology 366 (2012) 111–124 115(Wt1cre for short) mouse was constructed to enable cell fate tracing
of epicardially derived cells.
In order to put the results of our cell fate studies with the
Wt1cre mouse into context, we performed in situ hybridization
and immunoﬂuorescence studies to establish endogenous Wt1
mRNA and protein expression (Fig. 1). The tissue section in situ
experiments demonstrated cardiac expression of Wt1 mRNA in
the epicardium (Fig. 1(B) and (D)), in a subset of cells within the
ventricular myocardial wall, and in cells located within the
interventricular septum (Fig. 1(D)). Wt1 mRNA expression was
also seen in non-cardiac tissues, including the pericardial mem-
branes. The expression pattern of Wt1 protein, detected by
immunoﬂuorescence, was in accordance with that of Wt1 mRNA.
Thus, Wt1 protein expression was observed in the epicardium and
subepicardium (Fig. 1(E) and (F)), in isolated cells migrating into
the ventricular walls (Fig. 1(F)), and in a number of cells
throughout the interventricular septum (Fig. 1(E)). Importantly,
Wt1-positive cells were not observed in derivatives of the major
and lateral AV cushions (Fig. 1(E), see also Fig. 5).
For cell fate experiments, we used the R26-mT/mG mouse line,
in which EGFP is expressed in cells after cre-recombination
(Muzumdar et al., 2007). EGFP was detected immunoﬂuorescently
and cells that express EGFP in the reporter line after recombina-
tion with the Wt1cre mouse are in this paper referred to as Wt1cre-mG
cells (Fig. 1(G)). It is important to note that using the EGFP antibody,
we did not detect the mWt1/IRES/GFP-Cre fusion protein itself. Thus,
no antibody-binding was detected in Wt1cre mice that were not
crossed with the R26-mT/mG reporter mouse.
Contribution of epicardially derived cardiac ﬁbroblasts to compact
and trabeculated ventricular myocardium
Studies in the developing avian and murine heart have
demonstrated that EPDCs contribute to the developing cardiac
ﬁbroblast (CFs) population (Dettman et al., 1998; Gittenberger-de
Groot et al., 1998; Manner, 1999; Perez-Pomares et al., 2002) (Cai
et al., 2008; Wu et al., 2010; Zhou et al., 2010). However, partly
because of research emphases, as well as the nature of cell-fate
techniques used in the respective papers, these studies have not
provided a comprehensive insight into the extent of the epicardial
contribution to the CF population in the developing heart.
Furthermore, this aspect of epicardial development has not
received wide attention in studies in the mouse. To achieve a
better understanding of the involvement of EPDCs in this process,
we performed a cell fate analysis in hearts of Wt1cre-EGFP speci-
mens from ED10 until the neonatal stage.
The formation of the proepicardium in the mouse begins around
ED9 (Viragh and Challice, 1981). At this stage, the ventricular wall is
but a layer of thin myocardium lined by endocardium on the luminal
side. Shortly thereafter, at ED 10–10.5, epicardial cells have largely
covered the entire myocardial surface of the developing atria and
ventricles (Fig. 1(G) and Fig. 2(A,A0,A00)). The myocardial ventricular
wall of the right and left ventricle at this stage is just a few cell layers
thick and sparsely trabeculated. At ED12.5, two separate components
of the ventricular wall can be clearly distinguish; the compact and the
trabeculated myocardium (Fig. 2(B,B0,B00)). Analysis of Wt1cre-mG
hearts at this stage demonstrate the appearance of EGFP expressing
cells within the compact ventricular myocardium (Fig. 2(B0,B00)).
Slightly later in development, at ED13-14, EPDCs have migrated
toward the boundary between the compact and trabecular myocar-
dium and, as such, can be found throughout the compact layer of the
ventricular free walls (Fig. 2(C,C0,C00)). This restricted distribution of
Wt1cre-mG cells to the compact myocardium is maintained through
ED17 (Fig. 2(E) and Fig. 3) and it is not until the neonatal stage that
Wt1cre-mG positive cells are found in the ventricular trabecular
myocardium (Fig. 2(D,D0,D00,F)).The Wt1cre-mG positive EPDCs in the ventricular walls have a
mesenchymal/ﬁbroblastic phenotype, are highly polarized, with
their major axis lying parallel to neighboring cardiomyocytes
(Fig. 3(A) and (B)) and do not express myocardial speciﬁc genes
Fig. 4. Wt1cre-mG cells signiﬁcantly contribute to the formation of the atrioven-
tricular valve leaﬂets that derive from the lateral atrioventricular cushions.
Sections through the atrioventricular region of hearts at 12.5ED (A), (B), 14.5ED
(C), (D), 17ED (E), (F) and the neonatal stage (G), (H) were histologically stained for
HE (A), (C), (E), (G) and immunoﬂuorescently for EGFP expression (red, (B), (D), (F),
(H) and MF20 (green, (B), (D), (F), (H). The distribution of Wt1cre-mG cells clearly
demonstrates the increased and preferential contribution of EPDCs to the devel-
oping parietal leaﬂet of the right AV valve (B), (D), (F), (H). The small arrows in B
point to the EPDCs that migrate into the interface between the AV and ventricular
myocardium. Note in (B), (D), (F) and (H) the virtual absence of Wt1cre-mG cells in
the septal leaﬂet of the right AV valve. LA¼ left atrium, LV¼ left ventricle,
RA¼right atrium; RV¼right ventricle.
A. Wessels et al. / Developmental Biology 366 (2012) 111–124116(e.g. myosin heavy chain, Fig. 3(C) and (D)). To determine
whether, in addition to their morphological appearance, the
EPDCs located within the compact myocardial wall also express
ﬁbroblast-associated genes and to conﬁrm that the EGFP-positive
cells are indeed cardiac ﬁbroblasts, immuonohistochemical stu-
dies were performed. While there are no unique markers for CFs,
a wide variety of genes have been described that are typically
expressed by these cells including Collagen I, Vimentin and
FilaminA (Kim et al., 2010; Krenning et al., 2010; Norris et al.,
2010; Snider et al., 2009; Zeisberg and Kalluri, 2010). These
experiments showed co-expression of ﬁbroblast-associated genes
with the EGFP-positive EPDCs (Fig. 3(E)–(R)).
Epicardially derived cells preferentially contribute to the AV valve
leaﬂets derived from the lateral AV cushions
Valve interstitial cells (VICs) form an important group of
ﬁbroblasts in the heart and are found in the cardiac valves.
Although several studies have demonstrated that epicardially
derived cells (EPDCs) contribute to the mesenchyme of the
developing AV cushions (Gittenberger-de Groot et al., 1998;
Manner, 1999; Perez-Pomares et al., 2002), their contribution to
the formed AV valves of the four-chambered heart is a matter of
debate (de Lange et al., 2004). Using our Wt1cre mouse we have
revisited this important question.
In Wt1cre-mG hearts at ED12–13, at which point the two major
as well as the two lateral AV cushions have formed, the Wt1cre-mG
positive cells have densely populated the AV sulcus (Fig. 4(A) and
(B)). The distribution of Wt1cre-mG positive cells within the lower
boundary of the lateral AV junctional myocardium suggests that
this population of cells is actively migrating from the AV sulcus
through the AV myocardium toward the cushion/myocardium
interface of the right (Fig. 4(B)) and left (not shown) lateral AV
cushions which, at this stage, are relatively small compared to the
major AV cushions. At this stage, only a few Wt1cre-mG positive
cells can be found within the right lateral AV cushion (Fig. 4(B)).
The material contribution of Wt1cre-mG positive cells to the AV
cushions changes dramatically between ED13 and ED15. Hearts at
these stages show increasingly larger numbers of Wt1cre-mG cells
in the developing AV valve leaﬂets (Fig. 4(C) and (D)). This inﬂux
of Wt1cre-mG cells is essentially restricted to the leaﬂets that
derive from the lateral cushions, only very few Wt1cre-EGF positive
cells are seen in the leaﬂets that derived from the major AV
cushions at this and subsequent stages (Fig. 4(D), (F), and (H)).
The dramatic difference in the contribution of Wt1cre-mG positive
cells to the AV leaﬂets derived from the lateral cushions versus
those derived from the major cushions persists and becomes even
more pronounced as the heart matures throughout fetal development
and into the neonatal stage (Fig. 4(E)–(H) and Fig. 8(A) and (B)).
It is theoretically possible that EGFP expression in the AV valve
leaﬂets is not related to the inﬂux of EPDCs but rather results
from a transcriptional event that would activate the Wt1cre driver
in the resident population of endocardially derived cells. In that
case, one would expect to see an upregulation of endogenous Wt1
in these cells as well. To exclude this possibility, we performed
in situ hybridization to detect Wt1 mRNA on sections of wildtype
ED14.5 and neonatal hearts and determined that Wt1 mRNA is
not expressed in any of the leaﬂets of the AV valves (Fig. 5).
To verify that the Wt1cre-EGF positive EPDC population in the
lateral leaﬂets is indeed, like the endocardially derived cells in the
cushion derived tissues, giving rise to valve ﬁbroblasts, we
immunoﬂuorescently stained serial sections at ED17 for the
presence of genes characteristically expressed in the AV valves,
including Collagen I (Fig. 6(B)–(E)), Vimentin (Fig. 6(F), (H)–(J)),
FilaminA (Fig. 6(G), (K)–(M)), Periostin (not shown) and Versican
(not shown) and established that all these genes are indeedexpressed by the Wt1cre-EGF positive EPDCs. The expression
patterns of these genes showed a similar staining pattern in the
major and lateral cushions. Since we have shown that the
mesenchyme of the major cushions is largely endocardially
derived cells and the lateral cushion mesenchyme mainly consists
of epicardially derived cells, this shows that the endocardially and
epicardially derived cells have a very similar molecular proﬁle as
they differentiate into VICs.
Sox9, a member of the high-mobility-group of transcription
factors, is widely expressed in the mesenchyme of the AV
cushions (Lincoln et al., 2007; Smith et al., 2011) where it is
reportedly involved in the regulation of endocardial EMT
(Akiyama et al., 2004). More recent studies have also indicated
a role for Sox9 in epicardial development (Smith et al., 2011). To
obtain a better insight into the possible role of Sox9 in the
epicardial involvement of AV valve formation we performed
Fig. 5. Mesenchyme of the developing AV valve leaﬂets does not express Wt1.
Non-radioactive in situ hybridization on serial sections of ED14.5 (A) and (B) and
neonatal hearts collected right after birth (C) and (D) with probes for cardiac
Troponin I (A) and (C) and Wt1 (B), (D) shows the absence of Wt1 mRNA
expression in the developing parietal and septal leaﬂets of the right AV valve.
IVS¼ interventricular septum, LV¼ left ventricle, RA¼right atrium, RV¼right
ventricle.
Fig. 6. Wt1cre-mG cells in the lateral leaﬂets of the AV valves express genes
associated with differentiating valve ﬁbroblasts. Sections of 17EDWt1cre-mG hearts
were immunoﬂuorescently labeled for EGFP (red), MF20 (green in A and blue in
(F)–(M), Collagen I (green in (B), (C), and (E), Vimentin (green in (F), (H), and (J),
and FilaminA (green in (G), (K), and (M). The nuclei in sections (A)–(E) were
visualized by DAPI staining (blue), Panel C is an enlargement of the boxed area in
(B), panel (H) is an enlargement of the boxed area in (F), and panel (K) is an
enlargement of the boxed area in (G). The co-labeling of the valve leaﬂets at the
left AV junction shows that the Wt1cre-mG positive cells are co-expressing
characteristic ﬁbroblast-associated proteins that are also found in the non-
epicardially derived cushions, including Collagen 1 (B)–(E), Vimentin (F) and
(H)–(J) and FilaminA (G) and (K)–(M).
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experiments showed that while Sox9 is expressed at a very low
level in the epicardial epithelium itself (Fig. 7(D) and (G)), the
expression of Sox9 is much higher in the Wt1cre-mG expressing
EPDCs that are closer in proximity to the AV myocardium and
those that are migrating into the myocardial junction (Fig.7(B),
(C), (E)). Within the developing leaﬂets no difference was
observed between the levels of Sox9 expression in the epicar-
dially derived mesenchyme and the endocardially derived
mesenchyme (Fig. 7(D)).
Epicardially derived cells preferentially populate the AV valve leaﬂets
that derive from the lateral AV cushions
It has been well-established that the early formation of the AV
cushions involves an epithelial-to-mesenchymal transition (EMT)
of the endocardium and that the mesenchyme found in these
extracellular matrix-rich tissues is entirely endocardially derived
(Eisenberg and Markwald, 1995). Furthermore, we and others
have previously suggested that as this endocardially derived
mesenchyme expands and differentiates, it also provides the
tissue base for the VICs found in the leaﬂets of the developed
AV valves (Wessels et al., 1996; de Lange et al., 2004). These
studies, have led to the paradigm that mature valve leaﬂets do not
contain a substantial amount of cells from the myocardial, neural
crest, or epicardial cell lineages (de Lange et al., 2004). The results
from our Wt1cre-mG cell fate study described in this report,
however, demonstrate that during late fetal development the
developing VIC population in a subset of the AV valve leaﬂets,
i.e.the parietal leaﬂet of the right AV valve and the mural leaﬂet of
the left AV valve, largely consists of epicardially derived cells
(Fig. 8(A) and (B)). This brought into question the conclusions
regarding the endocardial origin of all valvular mesenchymal/
ﬁbroblasts in the developed AV valves. To revisit this matter we
used the Tie2cre mouse (Kisanuki et al., 2001) in combination with
the R26-mT/mG mouse for tracing of endocardial and endocar-
dially derived cells and compared the expression of Tie2cre-mG
(Fig. 8(C)–(F)) to the Wt1cre-mG expression in hearts at two
prenatal developmental stages (ED12-12.5 and ED14.5-15) and
in the neonatal heart (see also Fig. 4).
In ED12 Tie2cre-mG hearts, the entire endocardium, and vir-
tually all mesenchymal cells of the AV cushions, express EGFP
demonstrating the endocardial origin of nearly all cells that form
the lateral and major AV cushions at this stage (Fig. 8(C)). Asdescribed above, very few EGFP positive cells are found in
Wt1cre-mG hearts at this stage (Fig. 4(B)), indicating a very limited
contribution of the epicardium to the developing leaﬂets in this
early developmental period.
As discussed earlier, and as demonstrated in ED14-14.5 Wt1cre-mG
hearts, the lateral cushions become populated with EGFP labeled
cells, whereas virtually no labeled cells are found in the derivatives of
the major AV cushions at this stage (Fig. 4(D)). In Tie2cre-mG hearts
around the same developmental stage, all developing AV valve
leaﬂets still contain large numbers of EGFP-expressing endocardially
derived cells (Fig. 8(D)). Thus, at this mid-embryonic stage, epicar-
dially and endocardially derived cells are intermingled in the lateral
cushions, but the mesenchyme of the major cushions continues to be
predominantly endocardially derived.
Fig. 7. Sox9 is expressed in the Wt1cre-mG cells that populate the lateral leaﬂets of the AV valves. Tissue sections of 13ED (A)–(C) and 17ED (D)–(F) hearts of Wt1cre-mG
specimens were immunoﬂuorescently triple-labeled for EGFP expression (red), MF20 (blue) and Sox9 (green). The panels demonstrate that as EGFP labeled EPDCs migrate
into the AV sulcus the level of Sox9 expression increases and that once the EPDCs have populated the AV valve leaﬂets their Sox9 expression proﬁle is indistinguishable
from that of the endocardially derived valve mesenchymal cells. Tissue-section in situ hybridization for Sox9 in a 13.5ED heart (G) and (H) also shows that mesenchymal
cells in the AV sulcus that are in close proximity to the AV junctional myocardium express a higher level of Sox9 mRNA when compared to the epicardial and epicardially
derived cells located further away from the junctional myocardium. Panel I shows a control in situ labeling with a cTnI probe. LA¼ left atrium, LV¼ left ventricle, RA¼right
atrium; RV¼right ventricle.
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strates that epicardially- and endocardially derived cells differ-
entially contribute to the valvuloseptal complex of the developed
heart. The parietal leaﬂets of neonatal Wt1cre-mG hearts show
intense staining for EGFP indicating that the vast majority of the
VICs are of epicardial origin. Very few Wt1cre-mG labeled cells are
observed in the septal leaﬂet of the right AV valve and the aortic
leaﬂet of the left AV valve, indicating that these leaﬂets do not
receive a signiﬁcant contribution from the epicardium (Fig. 4(G)
and (H) and Fig. 8(A) and (B)). The labeling of the Tie2cre-mG
neonatal hearts demonstrated that at this stage only few Tie2cre-mG
positive cells can be observed within the mesenchyme of the
parietal leaﬂet and that Tie2cre-mG staining is virtually restricted
to the endocardial lining (Fig. 8(E) and (F)). Thus, whereas the
mesenchyme of all leaﬂets is initially derived from an endocardial
EMT, the population of VICs in the parietal leaﬂets of the post
natal heart largely consists of EPDCs. In contrast, the vast majority
of the VICs in the leaﬂets that derive from the major cushions, i.e.
the septal leaﬂet of the right AV valve and the aortic leaﬂet of the
left AV valve (Fig. 8(F)), remain Tie2cre-mG positive, indicating that
this cell population is still largely endocardially derived cells in
the postnatal heart (Fig. 8(C) and (D)).
Myocardial expression of Wt1cre-mG in cells of the interventricular
septum
While it is generally accepted that EPDCs give rise to coronary
smooth muscle cells and cardiac ﬁbroblasts, their contribution to
the coronary endothelium and cardiomyocyte population remains
contentious, particularly because studies in the avian model
systems and the mouse appear to lead to different conclusions.The apparent contradictory observation regarding the coronary
endothelium was addressed in a recent paper (Katz et al., 2012) in
which, using Sema3DeGFPcre knock-in and ScxGFPCre BAC transgenic
mice, it was demonstrated that the Scx and Sema3D cell popula-
tions from the proepicardium give rise to the coronary endothelial
cells, an observation which seems to largely resolve the hitherto
unresolved divergent observations in the epicardial cell fate
studies in the developing avian and murine heart.
The question of whether the epicardium materially contributes to
the developing myocardium remains highly contentious. The initial
cell fate studies in the avian heart never indicated a contribution of
EPDCs to the developing myocardium (Dettman et al., 1998;
Gittenberger-de Groot et al., 1998; Perez-Pomares et al., 2002). A
few years ago, however, a number of epicardial cell-fate studies were
published in which, using respectively a Tbx18:cre mouse and a
Wt1GFPCre mouse, it was suggested that the epicardium signiﬁcantly
contributes to subpopulations of cardiomyocytes (Cai et al., 2008;
Zhou et al., 2008) . More recently, this observation seemed to be
conﬁrmed in a study by the Tabin lab (Katz et al., 2012). To determine
whether, and if so how, cells that are labeled with our Wt1cre
construct contribute to the developing myocardium we analyzed
Wt1cre-mG hearts at different stages. At early stages, Wt1cre-mG
positive cardiomyocytes are predominantly seen in the ventricular
apex (Fig. 9(A)–(E)), but as ventricular septation progresses, these
Wt1cre-EGFP positive embryonic cardiomyoctes are also found dis-
persed throughout the interventricular septum, often in small clusters
suggesting a clonal origin (Fig. 9(G)–(I)). The morphology of
these Wt1cre-EGFP/MF20 positive cells resembles that of the neighbor-
ing Wt1cre-EGFP-negative cardiomyocytes and is quite distinct from
the Wt1cre-EGFP cells with a ﬁbroblastic phenotype and which do not
express myocardial markers (see, e.g., Fig. 3(B) and (C)).
Fig. 8. Epicardially derived cells replace the endocardially derived mesenchyme of the developing parietal leaﬂet of the right AV valve. EGFP immunoﬂuorescent labeling
(red) of sections of a neonatal Wt1cre-mG heart (A) and (B) shows the contribution of EPDCs to the parietal leaﬂet of the right AV valve (A) and the mural leaﬂet of the left AV
valve. The panels also show the absence of EPDCs in the septal leaﬂet of the right AV valve (A) and the aortic leaﬂet of the left AV valve (B). Panels (C) through F show EGFP
immunoﬂuorescent labeling (red) of sections of Tie2cre-mG hearts at 12ED, 15ED and neonatal stage co-labeled with MF20 (green). The plate illustrates that at the right AV
junction where initially the mesenchyme of all the AV cushions is largely endocardially derived (C) and (D), the endocardially derived mesenchyme of the parietal leaﬂet,
but not that of the septal leaﬂet, becomes replaced by epicardially derived cells (A), (E), and (F). Note in (E) and (F) that the endocardial lining of the parietal leaﬂet
continues to be marked by Tie2cre-mG. iAVC¼ inferior AV cushion, sAVC¼superior AV cushion, llAVC¼ left lateral AV cushion, rl¼right lateral AV cushion.
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Until a few years ago, our knowledge of the contribution of
EPDCs to cardiac development was, by and large, limited to the
avian heart. In a series of studies using dye-labeling and quail-to-
chick proepicardial explant techniques, in which donor tissues
containing quail proepicardium were transplanted into stage-
matched chick host embryos, EPDCs were shown to migrate into
the ventricular myocardium and into the AV cushions (Dettman
et al., 1998; Gittenberger-de Groot et al., 1998; Manner, 1999;
Perez-Pomares et al., 2002; Wessels and Perez-Pomares, 2004).
These and other studies also demonstrated the potential of EPDCs
to differentiate into a number of different cell types leading to the
notion that the EPDC can be considered a multipotent cardiac
stem cell (Wessels and Perez-Pomares, 2004; Winter and
Gittenberger-de Groot, 2007; Winter et al., 2009). Notwithstand-
ing the signiﬁcant insight these studies yielded in the aviansystem, the technical nature of these approaches left many
unanswered questions. While the development of Cre mice has
broadened our understanding of the role of epicardium in the
murine heart models (Cai et al., 2008; Katz et al., 2012; Zhou
et al., 2008, 2010), these studies have also led to new questions
regarding speciﬁc aspects of the role of the epicardium in cardiac
development.
In this paper we report the use of another cre-mouse which,
like the one generated by Zhou and colleagues (Zhou et al., 2008,
2010), is based on the characteristic epicardial expression of the
Wilm’s Tumor 1 transcription factor (Wt1). Although this mWt1/
IRES/GFP-Cre mouse has previously been used (del Monte et al.,
2011; Norden et al., 2010), this is the ﬁrst report in which its
potential in the study of epicardial cell fate is documented in detail.
The use of this mouse in combination with the R26-mT/mG reporter
mouse (Muzumdar et al., 2007) enabled us to trace in great detail the
fate of EPDCs and to address a number of important issues,
Fig. 9. A small subpopulation of cardiomyocytes is EGFP labeled in Wt1cre-mG
hearts. Immunoﬂuorescent co-labeling for EGFP (red), MF20 (green) and DAPI
nuclear stain (blue) of ED12.5 (A)–(E) and ED17 Wt1cre-mG hearts shows that a
subpopulation of MF20 positive cardiomyocytes are also Wt1cre-mG positive. Panel
(B) is an enlargement of boxed area in (A), panels (C), (D), and (E) are enlarge-
ments of boxed area in (B). Panel (G) is an enlargement of boxed area in (F), panels
(H), (I), and (J) are enlargements of boxed area in (G). The respective panels
demonstrate that Wt1cre-mG/MF20 positive cardiomyocytes are predominantly
located in the interventricular septum. IVS¼ interventricular septum, LV¼ left
ventricle, RV¼right ventricle.
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ﬁbroblast population in the murine heart.
The epicardium and the development of the interstitial cardiac
ﬁbroblasts
Although there is still some debate regarding the origin of the
respective ﬁbroblast populations in the developing and adult heart in
health and disease (Krenning et al., 2010; Snider et al., 2009; Zeisberg
and Kalluri, 2010), a series of studies in recent years has demon-
strated that the epicardium should be considered as a signiﬁcant
source of these cells (Dettman et al., 1998; Gittenberger-de Groot
et al., 1998; Manner, 1999; Perez-Pomares et al., 2002; Cai et al.,
2008; Katz et al., 2012; Wu et al., 2010; Zhou et al., 2010). The data
presented here, provide new information on how EPDCs populate the
ventricular myocardial wall and septum to contribute to the ven-
tricular interstitium. We show that EPDCs begin to invade the
ventricular myocardial walls around ED12.5. Using a quail-to-chickchimera model at Hamburger/Hamilton stage 26 (H/H 26), which is
comparable to murine ED12.5 (Wessels and Markwald, 2000), we
found that in the avian heart EPDCs start to invade the ventricular
walls around this stage as well (Wessels and Perez-Pomares, 2004).
By ED 14, epicardially derived ﬁbroblasts have populated the compact
layer of the myocardium. The formation of this densely packed layer
of ventricular cardiomyocytes is frequently linked to the development
of the epicardium as mice with disrupted epicardial development
typically present with a thin compact ventricular wall (for a review
see Wessels and Perez-Pomares (2004)). Likewise, when epicardial
development in the developing avian heart is perturbed by micro-
surgical procedures, the experimental hearts also are found to have a
thin ventricular wall (Gittenberger-de Groot et al., 2000; Perez-
Pomares et al., 2002). Here we show that the early development of
the compact layer precedes the ingrowth of EPDCs into the ventri-
cular wall. This indicates that the initial formation of the compact
layer does not rely on the migration of EPDCs into the myocardial
wall. The subsequent increase in wall thickness does coincide with
the inﬂux of EPDCs into the compact layer. This might suggest that
this second phase of ventricular wall development, which involves
continued proliferation of the myocardium (Ieda et al., 2009) and the
establishment of a coronary network, does depend on concomitant
development of the EPDC-derived interstitium. In a recent study on
the role of PDGF receptor signaling in epicardial development,
however, the paradigm that epicardially derived cardiac ﬁbroblasts
are important for normal myocardial development was challenged
(Smith et al., 2011). It is obvious that more research is needed to
unravel the importance of EPDCs in this process. The migration of
EPDCs into the trabecular myocardium was found to be a very late
process, taking place right before birth as at ED17 the EPDCs are still
largely conﬁned to the compact myocardium and it is not until the
neonatal stage that signiﬁcant numbers of EPDCs in the trabecular
myocardium are observed. Based on these observations, we infer that
there are two important developmental windows related to the
migration of EPDCs into the compact and trabecular ventricular
myocardium. The ﬁrst, ED12 through ED14, is a critical phase in the
development of the EPDCs that populate the compact ventricular
myocardium and give rise to the cardiac interstitial ﬁbroblasts (CFs)
and other epicardially derived cell types, speciﬁcally the vascular
smooth muscle cells of the coronary network. The second phase, the
migration of these cells into the trabecular myocardium, is a very late
gestational event, occurring around birth. How this phased develop-
ment of the cardiac interstitial ﬁbroblasts is regulated is unknown.
The initial step for the ﬁrst phase in the entire process is epicardial
EMT. Factors regulating this process and subsequent migration of
EPDCs into the subepicardial space and into the underlying myocar-
dium have been identiﬁed and include PDGF-B and PDGFRb, Tbx5,
thymosin b4, Ets factors, and Sox9 (Lie-Venema et al., 2003, 2007;
Smith et al., 2011). A mechanism of particular interest is the FGF10/
FGFR2b signaling pathway. In a recent publication by the Ornitz lab
(Vega-Hernandez et al., 2011), it was demonstrated that myocardial
FGF10 signaling to epicardial and epicardially derived cells through
FGFR2b induces cardiac ﬁbroblast development. Whether, and if so
how, these and other candidates are involved in the spatial and
temporal regulation of the migration of the epicardially derived cells
into the compact myocardium remains to be established. Another
challenge is the elucidation of the mechanism responsible for the
delayed migration of EPDCs into the trabecular myocardium. Genes
that during development show elevated levels of expression in the
trabecular myocardium include ANF, BMP10, and p57Kip2 (Gaussin
et al., 2002; Moorman and Christoffels, 2003; Snider et al., 2007).
Whether these or other genes play a role in regulating EPDC
immigration into the trabeculae, and whether EPDCs play a speciﬁc
role in postnatal cardiac growth and remodeling of the trabecular
component of the heart, will be subject for further research. Based on
the observation that EPDCs appear in the trabecular myocardium very
A. Wessels et al. / Developmental Biology 366 (2012) 111–124 121late in developmental terms, we infer that they likely do not play a
signiﬁcant role in trabecular development.
The epicardium and AV insulation
As the primary heart tube develops and loops, there is initially
myocardial continuity between the developing atrial and ventri-
cular myocardium (Bakker et al., 2010). The cardiomyocytes of
the AV junctional myocardium are characterized by a series of
unique molecular and functional features which serve to delay
the cardiac impulse, generated in the sinoatrial region, enabling
coordinated contraction of the atrial and ventricular chambers
(Wessels et al., 1996, 1992, 1991, 1990; Bakker et al., 2010; de
Jong et al., 1992; Aanhaanen et al., 2011). Later in development, a
ring of insulating ﬁbrous tissue, the annulus ﬁbrosus serves this
purpose. Incomplete separation of atrial and ventricular myocar-
dium, or de-novo formation of myocardial atrioventricular con-
nections, can result in accessory atrioventricular pathways which
can serve as anatomical substrates for ventricular pre-excitation
as observed in patients with Wolff–Parkinson–White (WPW)
syndrome. In earlier papers on the developing human heart, we
showed that the separation of atrial and ventricular tissues occurs
at the lower boundary of the atrioventricular junction and results
in the incorporation of the embryonic AV myocardium into the
lower rim of the atrial chambers (Wessels et al., 1996, 1992). The
data presented here conﬁrms earlier studies that this separation
of ventricular and atrioventricular/atrial myocardium is achieved
by active migration of EPDCs into the lower boundary of the
junctional myocardium (Zhou et al., 2010). It also demonstrates
that after doing so, the immigrating EPDCs create a portal of entry
that allows them to populate the lateral AV cushions. As the
EPDCs migrate away from the epicardial epithelium into the AV
sulcus and toward the AV myocardium, they gradually assume a
mesenchymal phenotype similar to that of the endocardially
derived cushion mesenchymal cells. This includes the expression
of Sox9, FilaminA, collagen I, and vimentin. It is important to note
that the separation of atrial and ventricular myocardium does not
take place in the postero-inferior aspect of the heart. Here, AV
myocardial continuity is maintained through the bundle of His (or
AV bundle), an integral part of the AV conduction system.
The epicardium and the development of the AV valves
Despite our increasing knowledge on the role of the epicardium in
heart development, many contentious topics still remain, including
the involvement of EPDCs in the formation of the AV valves. Although
initial quail-to-chick chimera studies, strongly suggested that during
valvulogenesis, EPDCs migrate into the developing AV valve leaﬂets,
little attention was given to the speciﬁc contribution of these cells to
the individual leaﬂets (Gittenberger-de Groot et al., 1998; Manner,
1999; Perez-Pomares et al., 2002). The importance of EPDCs for
proper valvuloseptal morphogenesis was demonstrated in studies in
which the development of the epicardium was perturbed by either
ablation of the proepicardium or through insertion of a piece of
eggshell in between the proepicardium and the heart proper to delay
the attachment of proepicardial cells to the myocardial surface of the
heart. These studies showed that inhibition of normal epicardial
growth results in cardiac abnormalities including malformations of
the valvuloseptal apparatus (Perez-Pomares et al., 2002). A few years
ago, however, a paper was published in which it was suggested that
the mesenchyme found in the derivatives of the major and lateral AV
cushions is entirely endocardially derived (de Lange et al., 2004).
In this study, which was mainly based on cre-lineage tracing
experiments, the authors also incorporated results from quail-to-
chick proepicardial chimera studies, stating that in the AV valve
leaﬂets of the developed chimera heart no quail derived cells could befound. They inferred from these observations that the EPDCs that can
be observed to populate the valves in early stages of development do
not survive (or disappear) from these tissues at later stages. Com-
bined, these observations raised the question of what the role of the
epicardium is in the development of the valvuloseptal complex in the
murine heart.
In this study we report that EPDCs, migrate through the AV
junction, to gradually populate the lateral AV cushions and, to a
signiﬁcantly lesser extent, the major AV cushions, a process that
begins around ED12. Eventually, the EPDCsmake up the vast majority
of the mesenchyme of the lateral leaﬂets. While the mechanisms that
drive the population of the lateral cushions by the EPDCs have yet to
be elucidated, it is tempting to speculate that they involve molecular
cues unique to the tissues that are found in the lateral AV junction
and/or cushions. The development of the lateral AV cushions has
historically received very little attention, notwithstanding the sig-
niﬁcant contribution they make to the mature leaﬂets of the AV
valves (Lamers and Moorman, 2002; Snarr et al., 2008) and the
involvement of these leaﬂets in pathologies of the heart, such as
mitral valve prolapse and Ebstein’s anomaly (Ho et al., 2000; Paranon
and Acar, 2008). The left lateral cushion gives rise to the mural (or
posterior) leaﬂet of the mitral valve, a leaﬂet that is commonly
observed to undergo myxomatous degeneration in the pathology of
mitral valve prolapse. The right lateral cushion gives rise to the
parietal leaﬂet of the right AV valve (mouse) or the antero-superior
leaﬂet of the tricuspid valve in the human heart (Lamers et al., 1995).
Little is known regarding why the lateral AV cushions, when
compared to the major AV cushions, develop relatively late in
development (de Lange et al., 2004; Wessels et al., 1996) and it is
yet to be determined whether the well-studied molecular mechan-
isms that drive the formation of the major AV cushions (Eisenberg
and Markwald, 1995; MacGrogan et al., 2011; Sugi et al., 2004) are
also responsible for the formation of the lateral cushions. In this
context it is important to note that in several respects their develop-
ment does not mimic that of the major AV cushions. For instance, the
development of the lateral cushions does not involve an initial stage
in which they are seen as acellular puffy subendocardial spaces ﬁlled
with signiﬁcant amounts of extracellular matrix components. In fact,
it appears that endocardial EMT is the driving force in the develop-
ment of the lateral cushions. However, the lateral cushions never
accumulate large amounts of endocardially derived cells. As demon-
strated in this paper, the growth of the leaﬂets that derive from the
lateral cushions, and hence the development of the mesenchyme/
valvular ﬁbroblasts therein, seems to rely heavily on the inﬂux of
EPDCs. Our current observations regarding the preferential migration
of EPDCs into the lateral AV cushions and the importance of these
cushions to valvuloseptal morphogenesis emphasizes that more
research is needed to elucidate themolecular mechanisms underlying
their development in both health and disease. While at present there
is no evidence that EPDCs play a role in the valve pathologies that
affect speciﬁc components of the valvular apparatus more than
others, e.g. Ebstein’s Anomaly or Myxomatous Valve Disease, the
differential contribution of EPDCs to the respective leaﬂets under-
scores the importance of understanding the spatiotemporal contribu-
tion of EPDCs to the heart.
Wt1cre-mG expression in the myocardium
The potential of EPDCs to differentiate into cardiomyocytes
also continues to be a matter of controversy. In the early quail-to-
chick proepicardial transplant studies, (pro)epicardially derived
cardiomyocytes were never observed (Manner, 1999; Perez-
Pomares et al., 2002). In vitro studies show, however, that under
standard culture conditions, (pro)epicardial cells will readily
differentiate into cardiomyocytes (Kruithof et al., 2006). From
these observations it was inferred that, while EPDCs have the
A. Wessels et al. / Developmental Biology 366 (2012) 111–124122potential to undergo myocardial differentiation, during normal
avian cardiac morphogenesis proepicardial cells do not differenti-
ate into cardiomyocytes (van Wijk et al., 2006). A few years ago,
this paradigm was challenged in the work by two different
groups. Using a Tbx18:cre mouse model, Cai and colleagues
presented data that suggested that a large population of myocytes
in the interventricular septum, as well as more isolated patches of
cardiomyocytes within the walls of the heart, have an epicardial
origin (Cai et al., 2008). An epicardial origin for a cardiomyocyte
subpopulation was also suggested by Zhou and colleagues (Zhou
et al., 2008), who used a Wt1GFPCre and an inducible Wt1CreERT2
mouse to perform epicardial cell trace experiments. While the
distribution of the Wt1-cre labeled cardiomyocytes in the repor-
ter mouse used by Zhou and co-workers differed from the one
reported with the Tbx18-cre mouse, the general pattern of cre-
induced lacZ expression was rather similar. The interpretation of
the data in the Tbx18-cre mouse was challenged by Christoffels
and colleagues who showed that the observed myocardial stain-
ing could be explained by the endogenous expression of Tbx18 in
the myocardial cell lineage (Christoffels et al., 2009). Recently, the
Tabin laboratory published an epicardial cell fate study using two
new epicardial-cre models; the Sema3DeGFPcre and the ScxGFPCre
mouse. Although the studies in this paper were focused on
investigating the epicardial origin of coronary endothelium, they
also reported that, speciﬁcally when using the ScxGFPCre mouse in
combination with the ROSA26-lacZ, a signiﬁcant amount of right
ventricular myocardium in the right ventricular wall gets labeled.
It is noteworthy that even though the use of every single
epicardial-cre in combination with ROSA26 reporter mice does
lead to labeling of subsets of myocardial cells, the distribution of
labeled myocardial cells signiﬁcantly differs frommodel to model.
As has been discussed by others (Christoffels et al., 2009; Katz
et al., 2012) the use of ‘‘tissue-speciﬁc’’ cre mice carries the
inherent risk that the cre-recombinase might be leaky and will
recombine in other cell types than the one which is speciﬁcally
being targeted and/or that low levels of the factors that drive the
cre-constructs are being expressed in these cells. The labeling in
our Wt1cre-mG hearts does not show the intense and extensive
staining observed in the above mentioned studies in which the
ROSA26-lacZ reporter mouse was used. While the relatively low
number of Wt1cre-EGFP positive myocytes in the interventricular
septum seems to correlate with the distribution of Wt1 mRNA
expressing cells, we have not observed co-expression of Wt1
protein with Wt1cre-EGFP and MF20 in triple immunoﬂuorescent
labeling studies. Thus, while our epicardial cell-fate experiments
certainly do not show the extensive myocardial staining seen in
previous studies (Cai et al., 2008; Zhou et al., 2008), we cannot
exclude the possibility that a subset of myocardial cells may share
a common progenitor with the epicardium or may actually be
epicardially derived.Conclusions
Using an mWt1/IRES/GFP-Cre (Wt1Cre) mouse we have studied
the contribution of epicardially derived cells (EPDCs) to the
developing mouse heart with emphasis on the emerging popula-
tions of ﬁbroblasts and ﬁbroblast-like cells. In concordance with
previous reports, we found that EPDCs contribute to the majority,
if not all, of the interstitial ﬁbroblasts found in the embryonic
myocardium. Remarkably, while epicardially derived ﬁbroblasts
start to migrate into the compact ventricular myocardium around
ED12, and have populated this myocardium by ED14, they do not
migrate into the trabecular myocardium until after ED17. Migra-
tion of EPDCs through the atrioventricular myocardium and into
the endocardially derived lateral atrioventricular cushions beginsaround ED12. As development progresses the epicardially derived
ﬁbroblasts eventually become the predominant cell type in the
leaﬂets that derive from these lateral cushions. Importantly, the
contribution of EPDCs to the leaﬂets derived from the major AV
cushions is very limited. This new paradigm in valve development
has signiﬁcant pragmatic consequences for experimental studies
and the interpretation of experimental results when using endo-
cardial and/or epicardial speciﬁc cre-mice. More importantly, this
new insight into the origins of the valvular mesenchyme of the
respective leaﬂets of the AV valves may lead to the development
of new testable hypotheses regarding the pathogenesis of cardiac
abnormalities and diseases that preferentially affect individual
leaﬂets of the AV valvuloseptal complex.Acknowledgments
The authors would like to thank Dr. Brian Snarr for helpful
discussions during preparation of the manuscript. The authors
also would like to acknowledge the ﬁnancial support by the
following grants: NCRR C06 RR018823, NCRR C06 RR015455,
3P20RR016434-10S1 (A.W., A.L.P. R.A.N.), NIH-NHLBI R01-
HL084285 (A.W.), NIH-NHLBI R01-HL055373 (J.B.E.B.), NIH 5T32
HL007260 (M.M.L), NIH 5T32-GM008716-12 (L.E.B.), AHA 09
GRNT2060075 (A.W.), AHA GIA 0455612Z (R.D.), AHA 0855946G
(R.D.), AHA 11PRE7310036 (L.E.B.), AHA 11SDG5270006 (R.A.N.),
The Foundation Leducq (Paris, France) Transatlantic Mitral Net-
work of Excellence grant 07CVD04 (R.A.N.), European Commu-
nity’s Sixth Framework Program Grant LSHM-CT-2005-018630
(M.J.B.v.d.H.B.v.W., J.M.P-P), Netherlands Heart Foundation Grant
1996M002 (M.J.v.d.H. and B.v.W.), and BFU-2009-07929 and
TERCEL Cooperative Research Network (J.M.P-P).References
Aanhaanen, W.T., Moorman, A.F., Christoffels, V.M., 2011. Origin and development
of the atrioventricular myocardial lineage: insight into the development of
accessory pathways. Birth Defects Res. A Clin. Mol. Teratol. 91, 565–577.
Acharya, A., Baek, S.T., Banﬁ, S., Eskiocak, B., Tallquist, M.D., 2011. Efﬁcient
inducible Cre-mediated recombination in Tcf21cell lineages in the heart and
kidney. Genesis 49, 870–877.
Akiyama, H., Chaboissier, M.C., Behringer, R.R., Rowitch, D.H., Schedl, A., Epstein,
J.A., de Crombrugghe, B., 2004. Essential role of Sox9 in the pathway that
controls formation of cardiac valves and septa. Proc. Nat. Acad. Sci. U.S.A. 101,
6502–6507.
Bakker, M.L., Christoffels, V.M., Moorman, A.F., 2010. The cardiac pacemaker and
conduction system develops from embryonic myocardium that retains its
primitive phenotype. J. Cardiovasc. Pharmacol. 56, 6–15.
Banerjee, I., Fuseler, J.W., Price, R.L., Borg, T.K., Baudino, T.A., 2007. Determination
of cell types and numbers during cardiac development in the neonatal and
adult rat and mouse. Am. J. Physiol. Heart Circ. Physiol. 293, H1883–1891.
Cai, C.L., Martin, J.C., Sun, Y., Cui, L., Wang, L., Ouyang, K., Yang, L., Bu, L., Liang, X.,
Zhang, X., Stallcup, W.B., Denton, C.P., McCulloch, A., Chen, J., Evans, S.M., 2008.
A myocardial lineage derives from Tbx18 epicardial cells. Nature 454,
104–108.
Christoffels, V.M., Grieskamp, T., Norden, J., Mommersteeg, M.T., Rudat, C., Kispert,
A., 2009. Tbx18 and the fate of epicardial progenitors. Nature 458. E8-9
(discussion E9-10).
de Jong, F., Opthof, T., Wilde, A.A., Janse, M.J., Charles, R., Lamers, W.H., Moorman,
A.F., 1992. Persisting zones of slow impulse conduction in developing chicken
hearts. Circ. Res. 71, 240–250.
de Lange, F.J., Moorman, A.F., Anderson, R.H., Manner, J., Soufan, A.T., de Gier-de
Vries, C., Schneider, M.D., Webb, S., van den Hoff, M.J., Christoffels, V.M., 2004.
Lineage and morphogenetic analysis of the cardiac valves. Circ. Res. 95,
645–654.
del Monte, G., Casanova, J.C., Guadix, J.A., MacGrogan, D., Burch, J.B., Perez-
Pomares, J.M., de la Pompa, J.L., 2011. Differential Notch signaling in the
epicardium is required for cardiac inﬂow development and coronary vessel
morphogenesis. Circ. Res. 108, 824–836.
Dettman, R.W., Denetclaw Jr., W., Ordahl, C.P., Bristow, J., 1998. Common
epicardial origin of coronary vascular smooth muscle, perivascular ﬁbroblasts,
and intermyocardial ﬁbroblasts in the avian heart. Dev. Biol. 193, 169–181.
Eisenberg, L.M., Markwald, R.R., 1995. Molecular regulation of atrioventricular
valvuloseptal morphogenesis. Circ. Res. 77, 1–6.
A. Wessels et al. / Developmental Biology 366 (2012) 111–124 123Gaussin, V., Van de Putte, T., Mishina, Y., Hanks, M.C., Zwijsen, A., Huylebroeck, D.,
Behringer, R.R., Schneider, M.D., 2002. Endocardial cushion and myocardial
defects after cardiac myocyte-speciﬁc conditional deletion of the bone
morphogenetic protein receptor ALK3. Proc. Nat. Acad. Sci. U.S.A. 99,
2878–2883.
Gittenberger-de Groot, A.C., Vrancken Peeters, M.P., Bergwerff, M., Mentink, M.M.,
Poelmann, R.E., 2000. Epicardial outgrowth inhibition leads to compensatory
mesothelial outﬂow tract collar and abnormal cardiac septation and coronary
formation. Circ. Res. 87, 969–971.
Gittenberger-de Groot, A.C., Vrancken Peeters, M.P., Mentink, M.M., Gourdie, R.G.,
Poelmann, R.E., 1998. Epicardium-derived cells contribute a novel population
to the myocardial wall and the atrioventricular cushions. Circ. Res. 82,
1043–1052.
Hajdu, Z., Romeo, S.J., Fleming, P.A., Markwald, R.R., Visconti, R.P., Drake, C.J., 2011.
Recruitment of bone marrow-derived valve interstitial cells is a normal
homeostatic process. J. Mol. Cell. Cardiol. 51, 955–965.
Ho, S.Y., Goltz, D., McCarthy, K., Cook, A.C., Connell, M.G., Smith, A., Anderson, R.H.,
2000. The atrioventricular junctions in Ebstein malformation. Heart 83, 444–449.
Icardo, J.M., Arrechedera, H., Colvee, E., 1993. The atrioventricular valves of the
mouse. I. A scanning electron microscope study. J. Anat. 182, 87–94., Pt 1.
Ieda, M., Tsuchihashi, T., Ivey, K.N., Ross, R.S., Hong, T.T., Shaw, R.M., Srivastava, D.,
2009. Cardiac ﬁbroblasts regulate myocardial proliferation through beta1
integrin signaling. Dev. Cell 16, 233–244.
Katz, T.C., Singh, M.K., Degenhardt, K., Rivera-Feliciano, J., Johnson, R.L., Epstein,
J.A., Tabin, C.J., 2012. Distinct compartments of the proepicardial organ give
rise to coronary vascular endothelial cells. Dev. Cell 22, 639–650.
Kim, H., Nakamura, F., Lee, W., Shifrin, Y., Arora, P., McCulloch, C.A., 2010. Filamin
A is required for vimentin-mediated cell adhesion and spreading. Am. J.
Physiol. Cell. Physiol. 298, C221–236.
Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson, J.A., Yanagi-
sawa, M., 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-
lineage analysis in vivo. Dev. Biol. 230, 230–242.
Kolditz, D.P., Wijffels, M.C., Blom, N.A., van der Laarse, A., Hahurij, N.D., Lie-
Venema, H., Markwald, R.R., Poelmann, R.E., Schalij, M.J., Gittenberger-de
Groot, A.C., 2008. Epicardium-derived cells in development of annulus ﬁbrosis
and persistence of accessory pathways. Circulation 117, 1508–1517.
Krenning, G., Zeisberg, E.M., Kalluri, R., 2010. The origin of ﬁbroblasts and
mechanism of cardiac ﬁbrosis. J. Cell. Physiol. 225, 631–637.
Kruithof, B.P., van Wijk, B., Somi, S., Kruithof-de Julio, M., Perez Pomares, J.M.,
Weesie, F., Wessels, A., Moorman, A.F., van den Hoff, M.J., 2006. BMP and FGF
regulate the differentiation of multipotential pericardial mesoderm into the
myocardial or epicardial lineage. Dev. Biol. 295, 507–522.
Lamers, W.H., Moorman, A.F., 2002. Cardiac septation: a late contribution of the
embryonic primary myocardium to heart morphogenesis. Circ. Res. 91,
93–103.
Lamers, W.H., Viragh, S., Wessels, A., Moorman, A.F., Anderson, R.H., 1995.
Formation of the tricuspid valve in the human heart. Circulation 91, 111–121.
Lie-Venema, H., Gittenberger-de Groot, A.C., van Empel, L.J., Boot, M.J., Kerkdijk, H.,
de Kant, E., DeRuiter, M.C., 2003. Ets-1 and Ets-2 transcription factors are
essential for normal coronary and myocardial development in chicken
embryos. Circ. Res. 92, 749–756.
Lie-Venema, H., van den Akker, N.M., Bax, N.A., Winter, E.M., Maas, S., Kekarainen,
T., Hoeben, R.C., deRuiter, M.C., Poelmann, R.E., Gittenberger-de Groot, A.C.,
2007. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal
and abnormal cardiac development. Sci. World J. 7, 1777–1798.
Lincoln, J., Kist, R., Scherer, G., Yutzey, K.E., 2007. Sox9 is required for precursor cell
expansion and extracellular matrix organization during mouse heart valve
development. Dev. Biol. 305, 120–132.
MacGrogan, D., Luna-Zurita, L., de la Pompa, J.L., 2011. Notch signaling in cardiac
valve development and disease. Birth Defects Res. A Clin. Mol. Teratol. 91,
449–459.
Manner, J, 1999. Does the subepicardial mesenchyme contribute myocardioblasts
to the myocardium of the chick embryo heart? A quail-chick chimera study
tracing the fate of the epicardial primordium. Anat. Rec. 255, 212–226.
Markwald, R.R., Fitzharris, T.P., Manasek, F.J., 1977. Structural development of
endocardial cushions. Am. J. Anat. 148, 85–119.
Mellgren, A.M., Smith, C.L., Olsen, G.S., Eskiocak, B., Zhou, B., Kazi, M.N., Ruiz, F.R.,
Pu, W.T., Tallquist, M.D., 2008. Platelet-derived growth factor receptor beta
signaling is required for efﬁcient epicardial cell migration and development of
two distinct coronary vascular smooth muscle cell populations. Circ. Res. 103,
1393–1401.
Merki, E., Zamora, M., Raya, A., Kawakami, Y., Wang, J., Zhang, X., Burch, J., Kubalak,
S.W., Kaliman, P., Belmonte, J.C., Chien, K.R., Ruiz-Lozano, P., 2005. Epicardial
retinoid X receptor alpha is required for myocardial growth and coronary
artery formation. Proc. Nat. Acad. Sci. U.S.A. 102, 18455–18460.
Moore, A.W., McInnes, L., Kreidberg, J., Hastie, N.D., Schedl, A., 1999. YAC
complementation shows a requirement for Wt1 in the development of
epicardium, adrenal gland and throughout nephrogenesis. Development 126,
1845–1857.
Moorman, A.F., Christoffels, V.M., 2003. Cardiac chamber formation: development,
genes, and evolution. Physiol. Rev. 83, 1223–1267.
Muzumdar, M.D., Tasic, B., Miyamichi, K., Li, L., Luo, L., 2007. A global double-
ﬂuorescent Cre reporter mouse. Genesis 45, 593–605.
Norden, J., Grieskamp, T., Lausch, E., van Wijk, B., van den Hoff, M.J., Englert, C.,
Petry, M., Mommersteeg, M.T., Christoffels, V.M., Niederreither, K., Kispert, A.,
2010. Wt1 and retinoic acid signaling in the subcoelomic mesenchyme controlthe development of the pleuropericardial membranes and the sinus horns.
Circ. Res. 106, 1212–1220.
Norris, R.A., Moreno-Rodriguez, R., Wessels, A., Merot, J., Bruneval, P., Chester, A.H.,
Yacoub, M.H., Hagege, A., Slaugenhaupt, S.A., Aikawa, E., Schott, J.J., Lardeux, A.,
Harris, B.S., Williams, L.K., Richards, A., Levine, R.A., Markwald, R.R., 2010.
Expression of the familial cardiac valvular dystrophy gene, ﬁlamin-A, during
heart morphogenesis. Dev. Dyn. 239, 2118–2127.
Paranon, S., Acar, P., 2008. Ebstein’s anomaly of the tricuspid valve: from fetus to
adult: congenital heart disease. Heart 94, 237–243.
Perez-Pomares, J.M., Phelps, A., Sedmerova, M., Carmona, R., Gonzalez-Iriarte, M.,
Munoz-Chapuli, R., Wessels, A., 2002. Experimental studies on the spatiotem-
poral expression of WT1 and RALDH2 in the embryonic avian heart: a model
for the regulation of myocardial and valvuloseptal development by epicar-
dially derived cells (EPDCs). Dev. Biol. 247, 307–326.
Prunotto, M., Caimmi, P.P., Bongiovanni, M., Cellular pathology of mitral valve
prolapse. Cardiovasc. Pathol. 19, e113–117.
Runyan, R.B., Markwald, R.R., 1983. Invasion of mesenchyme into three-dimen-
sional collagen gels: a regional and temporal analysis of interaction in
embryonic heart tissue. Dev. Biol. 95, 108–114.
Smart, N., Bollini, S., Dube, K.N., Vieira, J.M., Zhou, B., Davidson, S., Yellon, D., Riegler, J.,
Price, A.N., Lythgoe, M.F., Pu, W.T., Riley, P.R., 2011. De novo cardiomyocytes from
within the activated adult heart after injury. Nature 474, 640–644.
Smith, C.L., Baek, S.T., Sung, C.Y., Tallquist, M.D., 2011. Epicardial-derived cell
epithelial-to-mesenchymal transition and fate speciﬁcation require PDGF
receptor signaling. Circ. Res. 108, e15–26.
Snarr, B.S., Kern, C.B., Wessels, A., 2008. Origin and fate of cardiac mesenchyme.
Dev. Dyn. 237, 2804–2819.
Snarr, B.S., O’Neal, J.L., Chintalapudi, M.R., Wirrig, E.E., Phelps, A.L., Kubalak, S.W.,
Wessels, A., 2007a. Isl1 expression at the venous pole identiﬁes a novel role for
the second heart ﬁeld in cardiac development. Circ. Res. 101, 971–974.
Snarr, B.S., Wirrig, E.E., Phelps, A.L., Trusk, T.C., Wessels, A., 2007b. A spatiotem-
poral evaluation of the contribution of the dorsal mesenchymal protrusion to
cardiac development. Dev. Dyn. 236, 1287–1294.
Snider, P., Olaopa, M., Firulli, A.B., Conway, S.J., 2007. Cardiovascular development
and the colonizing cardiac neural crest lineage. Sci. World J. 7, 1090–1113.
Snider, P., Standley, K.N., Wang, J., Azhar, M., Doetschman, T., Conway, S.J., 2009.
Origin of cardiac ﬁbroblasts and the role of periostin. Circ. Res. 105, 934–947.
Sugi, Y., Yamamura, H., Okagawa, H., Markwald, R.R., 2004. Bone morphogenetic
protein-2 can mediate myocardial regulation of atrioventricular cushion
mesenchymal cell formation in mice. Dev. Biol. 269, 505–518.
van Wijk, B., van den Hoff, M., 2006. Epicardium and myocardium originate from a
common cardiogenic precursor pool. Trends Cardiovasc. Med. 20, 1–7.
Vasquez, C., Mohandas, P., Louie, K.L., Benamer, N., Bapat, A.C., Morley, G.E.,
Enhanced ﬁbroblast-myocyte interactions in response to cardiac injury. Circ.
Res. 107, 1011–1020.
Vega-Hernandez, M., Kovacs, A., De Langhe, S., Ornitz, D.M., 2011. FGF10/FGFR2b
signaling is essential for cardiac ﬁbroblast development and growth of the
myocardium. Development 138, 3331–3340.
Viragh, S., Challice, C.E., 1981. The origin of the epicardium and the embryonic
myocardial circulation in the mouse. Anat. Rec. 201, 157–168.
Waller 3rd, B.R., Wessels, A., 2000. Cardiac morphogenesis and dysmorphogenesis:
An immunohistochemical approach. Methods Mol. Biol. 135, 151–161.
Wessels, A., Markman, M.W., Vermeulen, J.L., Anderson, R.H., Moorman, A.F.,
Lamers, W.H., 1996. The development of the atrioventricular junction in the
human heart. Circ. Res. 78, 110–117.
Wessels, A., Markwald, R., 2000. Cardiac morphogenesis and dysmorphogenesis. I.
Normal development. Methods Mol. Biol. 136, 239–259.
Wessels, A., Perez-Pomares, J.M., 2004. The epicardium and epicardially derived
cells (EPDCs) as cardiac stem cells. Anat. Rec. 276, 43–57.
Wessels, A., Sedmera, D., 2003. Developmental anatomy of the heart: a tale of mice
and man. Physiol. Genomics 15, 165–176.
Wessels, A., Vermeulen, J.L., Verbeek, F.J., Viragh, S., Kalman, F., Lamers, W.H.,
Moorman, A.F., 1992. Spatial distribution of ’’tissue-speciﬁc’’ antigens in the
developing human heart and skeletal muscle. III. An immunohistochemical
analysis of the distribution of the neural tissue antigen G1N2 in the embryonic
heart; implications for the development of the atrioventricular conduction
system. Anat. Rec. 232, 97–111.
Wessels, A., Vermeulen, J.L., Viragh, S., Kalman, F., Lamers, W.H., Moorman, A.F.,
1991. Spatial distribution of ’’tissue-speciﬁc’’ antigens in the developing
human heart and skeletal muscle. II. An immunohistochemical analysis of
myosin heavy chain isoform expression patterns in the embryonic heart. Anat.
Rec. 229, 355–368.
Wessels, A., Vermeulen, J.L., Viragh, S., Kalman, F., Morris, G.E., Man, N.T., Lamers, W.H.,
Moorman, A.F., 1990. Spatial distribution of ’’tissue-speciﬁc’’ antigens in the
developing human heart and skeletal muscle. I. An immunohistochemical analysis
of creatine kinase isoenzyme expression patterns. Anat. Rec. 228, 163–176.
Winter, E.M., Gittenberger-de Groot, A.C., 2007. Epicardium-derived cells in
cardiogenesis and cardiac regeneration. Cell. Mol. Life Sci. 64, 692–703.
Winter, E.M., van Oorschot, A.A., Hogers, B., van der Graaf, L.M., Doevendans, P.A.,
Poelmann, R.E., Atsma, D.E., Gittenberger-de Groot, A.C., Goumans, M.J., 2009.
A new direction for cardiac regeneration therapy: application of synergistically
acting epicardium-derived cells and cardiomyocyte progenitor cells. Circ.
Heart Fail. 2, 643–653.
Wu, M., Smith, C.L., Hall, J.A., Lee, I., Luby-Phelps, K., Tallquist, M.D., 2010.
Epicardial spindle orientation controls cell entry into the myocardium. Dev.
Cell 19, 114–125.
A. Wessels et al. / Developmental Biology 366 (2012) 111–124124Zeisberg, E.M., Kalluri, R., 2010. Origins of cardiac ﬁbroblasts. Circ. Res. 107, 1304–1312.
Zeng, B., Ren, X.F., Cao, F., Zhou, X.Y., Zhang, J., 2011. Developmental patterns and
characteristics of epicardial cell markers Tbx18 and Wt1 in murine embryonic
heart. J. Biomed. Sci. 18, 67.
Zhou, B., Ma, Q., Rajagopal, S., Wu, S.M., Domian, I., Rivera-Feliciano, J., Jiang, D.,
von Gise, A., Ikeda, S., Chien, K.R., Pu, W.T., 2008. Epicardial progenitorscontribute to the cardiomyocyte lineage in the developing heart. Nature 454,
109–113.
Zhou, B., von Gise, A., Ma, Q., Hu, Y.W., Pu, W.T., 2010. Genetic fate mapping
demonstrates contribution of epicardium-derived cells to the annulus ﬁbrosis
of the mammalian heart. Dev. Biol. 338, 251–261.
